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The monoguanylation of (1S,2S)- and (1R,2R)-cyclohexane-1,2-
diamine affords chiral primary amine-guanidines, which have been 
used as chiral organocatalysts for the enantioselective Michael 
addition of aldehydes, particularly α,α-disubstituted, to maleimides. 
The reaction is carried out in the presence of imidazole as additive 
in aqueous DMF as solvent and affords the corresponding 
enantioenriched succinimides in high or quantitative yields and 
with enantioselectivities up to 96% ee. 
Theoretical calculations (DFT and M06-2X) suggest a different 
H-bond coordination pattern of the maleimide (C=O) and the 
catalyst (NH groups) as responsible for the enantioinduction 
switch observed when the reaction is carried out using these 
primary amine-guanidines or the previously reported primary 
amine-thioureas as organocatalysts. 
 
Introduction 
 
Maleimides are an important class of substrates, which have 
been successfully used in different asymmetric organocatalytic 
transformations.[1] Particularly, the organocatalytic functiona-
lization of maleimides provides easy access to chiral-substituted 
succinimide derivatives, which are compounds of interest due to 
the occurrence of the succinimide moiety in natural products and 
some clinical drug candidates.[2] In addition, succinimides can 
be transformed into other important compounds such as γ-
lactams,[3] which are significant in the treatment of epilepsy,[4] 
HIV,[5] neurodegenerative disease and depression.[6] 
The enantioselective Michael addition of carbon 
nucleophiles to maleimides is probably the most direct way of 
preparing enantioenriched succinimides following an 
organocatalytic approach.[1] This has been frequently achieved 
using pro-nucleophiles containing highly acidic Cα-hydrogens, 
by employing as organocatalysts chiral bifunctional compounds 
bearing both an acidic moiety and a tertiary amine.[1] Thus, 
enantioinduction is achieved after formation of transition states 
involving close coordination of the maleimide and the enolate 
generated after deprotonation by the basic tertiary amine. 
However, pro-nucleophiles bearing Cα-hydrogens that cannot be 
deprotonated by tertiary amines, such as aldehydes, require 
formation of the carbon nucleophile by other catalytic systems. 
Thus, the first enantioselective conjugate addition of aliphatic 
aldehydes to N-aryl-maleimides used α,α-phenylprolinol silyl 
ether as organocatalyst.[7] The corresponding succinimides were 
obtained with very high enantioselectivity through a proposed 
transition state involving the formation of an enamine after 
reaction of the secondary amine with the aldehyde. However, the 
use of α,α-disubstituted aldehydes as pro-nucleophiles resulted 
in much lower enantioselectivities. 
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Therefore, other organocatalysts suitable to be also 
employed with the “difficult” α,α-disubstituted aldehydes, 
leading to enantioenriched succinimides bearing contiguous 
quaternary-tertiary carbons, were subsequently developed.[1] The 
most common and successful have been those incorporating 
both primary amine and thiourea moieties,[8] such as the 
trifluoromethylated primary amine thioureas 1,[8a,b] 2[8a,b] and 
3,[8e] as well as the beyerane-containing thiourea 4,[8f] although 
noncovalent bifunctional organocatalysts based on the use of the 
primary amine of amino acids, combined to acid additives, have 
also been successfully used.[9] 
 
 The use of chiral guanidines as organocatalysts has 
experienced a strong development in the last years, taking 
advantage of their strong basic character and coordinating 
capabilities.[10] However, concerning their application as 
organocatalysts in enantioselective Michael addition of carbon 
nucleophiles to maleimides, their use has been rather limited. 
Only enantioselective processes involving deprotonation of 
some pro-nucleophiles bearing highly acidic Cα-hydrogens have 
been reported,[10] the use of aldehydes remaining unexplored. 
Recently, we have communicated the use of new chiral 
primary amine-guanidines as organocatalysts for the 
enantioselective addition of α,α-disubstituted aldehydes to 
maleimides with opposite enantioselection than when using 
related thioureas.[11] Herein, we present a full account of the use 
of these new amine-guanidines as chiral organocatalysts in the 
asymmetric Michael addition of aldehydes to maleimides 
leading to enantioenriched succinimides, improving their 
enantioselectivity and exploring the origin of the 
enantioinduction by theoretical calculations. 
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Results and Discussion 
The primary amine-guanidines 5a and 5b employed in this 
study were prepared directly in 50% yield by monoguanylation 
of (1S,2S)-cyclohexane-1,2-diamine (5 eq) with diisopropyl-
carbodiimide and dicyclohexylcarbodiimide, respectively, in 
THF at room temperature for 48 h (Scheme 1). 
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Scheme 1. Preparation of primary amine-guanidines 5. 
 
 
These primary amine-guanidines 5 were used as 
organocatalysts in the enantioselective Michael addition reaction 
of aldehydes to N-substituted maleimides. Firstly, the search for 
the optimal reaction conditions was tackled, and the reaction of 
isobutyraldehyde (6a) to N-phenylmaleimide (7a) was chosen as 
a model reaction (Table 1). Thus, the reaction between these two 
compounds organocatalyzed by primary amine-guanidine 5a (20 
mol-%) carried out in toluene as solvent at room temperature 
afforded the succinimide (R)-8aa in 51% yield and 76% ee 
(determined by chiral HPLC, see the Experimental Section) 
(Table 1, entry 1). The (R)-stereochemistry for this compound 
was assigned by comparison of the elution order of the 
corresponding enantiomers in chiral HPLC with those of the 
literature.[8b] The same reaction conditions were employed using 
primary amine-guanidine 5b as catalyst, resulting in a higher 
isolated yield for (R)-8aa, although only in a 48% ee (Table 1, 
entry 2). Therefore, the optimization study was continued using 
5a as organocatalyst. 
Other solvents, such as acetone, tert-butyl methyl ether 
(TBME), nitromethane or methanol were attempted, but the 
observed enantioselection for (R)-8aa resulted much lower than 
when using toluene (Table 1, entries 3-6). However, the use of 
DMF as solvent rose the enantioselectivity for (R)-8aa up to 
82%, although in moderate yield (Table 1, entry 7), whereas the 
use of water as solvent increased the isolated yield and reaction 
rate, while decreasing slightly the enantioselection (Table 1, 
entry 8). Therefore, we assayed combinations on DMF/water as 
reaction solvent (Table 1, entries 9-11), obtaining quantitative 
yields of (R)-8aa and a highest enantioselectivity of 88% using a 
2/1 mixture of DMF/water (v/v) (Table 1, entry 10).  
Once the most appropriate reaction solvent was found 
(DMF/water 2/1, v/v), we lowered the reaction temperature 
down to 15 ºC expecting to increase the enantioselectivity. 
However, the enantiomeric excess remained essentially 
unchanged and the reaction rate diminished considerably (Table 
1, entry 12). Lowering even more the reaction temperature 
practically stopped the reaction. In addition, lowering the 
catalyst loading to 10 mol-% also diminished the reaction rate 
and slightly the enantioselectivity for (R)-8aa (Table 1, entry 13). 
 
Table 1. Screening and optimization of the reaction conditions for the enantioselective Michael addition. 
 
Entry Catalyst (mol-%) Additive (mol-%) Solvent T  (ºC) t (d) Yield (%)[a] ee (%)[b] 
1 5a (20) - PhMe 25 2 51 76 (R) 
2 5b (20) - PhMe 25 2 90 48 (R) 
3 5a (20) - Acetone 25 2 47 57 (R) 
4 5a (20) - TBME 25 2 12 64 (R) 
5 5a (20) - MeNO2 25 2 30 46 (R) 
6 5a (20) - MeOH 25 2 15 68 (R) 
7 5a (20) - DMF 25 2 55 82 (R) 
8 5a (20) - H2O 25 1 70 80 (R) 
9 5a (20) - DMF/H2O[c] 25 2 99 85 (R) 
10 5a (20) - DMF/H2O[d] 25 2 99 88 (R) 
11 5a (20) - DMF/H2O[e] 25 2 99 84 (R) 
12 5a (20) - DMF/H2O[d] 15 3 88 87 (R) 
13 5a (10) - DMF/H2O[d] 25 3 99 83 (R) 
14 5a (20) PhCO2H (20) DMF/H2O[d] 25 1 99 84 (R) 
15 5a (20) NEt3 (20) DMF/H2O[d] 25 0.7 67 73 (R) 
16 5a (20) DABCO (20) DMF/H2O[d] 25 0.7 99 80 (R) 
17 5a (20) DBU (20) DMF/H2O[d] 25 0.7 73 76 (R) 
18 5a (20) Imidazole (20) DMF/H2O[d] 25 0.7 99 86 (R) 
19 5a (20) Imidazole (20) DMF/H2O[d] 0 2 99 91 (R) 
20 ent-5a (20) Imidazole (20) DMF/H2O[d] 0 2 98 91 (S) 
[a] Isolated yield after flash chromatography.[b] Enantioselectivities and absolute stereochemistry determined by chiral HPLC (Ref. 8b). [c] 1/1, v/v. [d] 
2/1, v/v. [e] 4/1, v/v. 
 
Subsequently, we explored the possible effect of the 
presence of some additives. Thus, the addition of benzoic acid 
(20 mol-%) to the reaction reduced slightly the enantioselection 
for (R)-8aa although increased the reaction rate (Table 1, entry 
14). We also attempted basic compounds as additives, 
considering reported observations that their presence accelerate 
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catalytic cycles when enamine-forming organocatalysts are 
involved.[12] Thus the addition of triethylamine (20 mol-%) 
diminished considerably the reaction time, although affording a 
lower enantioselection for (R)-8aa (Table 1, entry 15). In 
addition, the addition of a 20 mol-% of other organic bases such 
as 1,4-diazabicyclo[2.2.2]octane (DABCO) or 1,8-
diazabicyclo[5.4.0]-undec-7-ene (DBU) also increased the 
reaction rate, but still giving a lower ee for (R)-8aa than when 
no additive was added (Table 1, entries 16 and 17).  
However, the addition to the reaction mixture of a 20 mol-% 
of imidazole not only  increased the reaction rate and gave a 
quantitative yield of (R)-8aa, but also afforded a 86% ee, a 
similar value than when no basic additive was present (Table 1, 
entry 18). Under these last conditions, the reaction temperature 
was lowered down to 0 ºC, allowing the isolation of succinimide 
(R)-8aa in quantitative yield and in 91% ee (Table 1, entry 19). 
Thus, the addition of imidazole as additive allowed lowering 
down the reaction temperature and increasing the 
enantioselectivity of the process compared to when no additive 
was added.[11] 
Expecting to achieve an opposite enantioinduction, we 
prepared primary amine-guanidine ent-5a in 51% yield 
following the same procedure than in the case of its 
enantiomeric counterpart 5a, but starting from (1R,2R)-
cyclohexane-1,2-diamine. This primary amine-guanidine was 
employed as organocatalyst for the model reaction between 
isobutyraldehyde and N-phenylmaleimide, under the last 
mentioned reaction conditions, yielding the enantiomeric 
succinimide (S)-8aa in 98 yield and 91% ee (Table 1, entry 20).  
 
 
 
Once the best reaction conditions were established [5a (20 
mol-%), imidazole (20 mol-%), DMF/water (2/1, v/v), 0 ºC], we 
proceeded to extend the application of this organocatalytic 
methodology to other aldehydes and maleimides (Table 2). Thus, 
when isobutyraldehyde reacted with N-phenylmaleimides 
bearing halogens on the phenyl ring, such as a chloro atom at the 
3- and 4-position (7b and 7c) or a bromo atom at the 4-position 
(7d), the enantioselectivity for the quantitatively obtained 
succinimides (R)-8ab, (R)-8ac and (R)-8ad rose up to 95, 92 and 
96%, respectively (Table 2, entries 2-4). However, when an 
electron-releasing methoxy group was present onto the phenyl 
ring of the maleimide, as in the case of 7e, the enantioselectivity 
for the corresponding succinimide (R)-8ae resulted lowered to 
89% (Table 2, entry 5). In addition, the presence of a 4-acetoxy 
group, as in maleimide 7f, gave rise to the succinimide (R)-8af 
in 94% ee (Table 2, entry 6). 
 
 
Table 2. Michael addition of aldehydes to maleimides organocatalyzed by chiral primary amine-guanidine 5a. 
 
 
Entry Aldehyde Maleimide t (d) Succinimide Yield (%)[a] ee (%)[b,c] 
 R1 R2 No. R3 No.     
1 Me Me 6a Ph 7a 2 (R)-8aa 99 91 
2 Me Me 6a 3-ClC6H4 7b 3 (R)-8ab 99 95 
3 Me Me 6a 4-ClC6H4 7c 3 (R)-8ac 99 92 
4 Me Me 6a 4-BrC6H4 7d 2 (R)-8ad 97 96 
5 Me Me 6a 2-MeOC6H4 7e 2 (R)-8ae 95 89 
6 Me Me 6a 4-AcOC6H4 7f 2 (R)-8af 98 94 
7 Me Me 6a Bn 7g 2 (R)-8ag 99 87 
8 Me Me 6a Me 7h 2 (R)-8ah 99 89 
9 Me Me 6a H 7i 1 (R)-8ai 99 84 
10 Et Et 6b Ph 7a 4 (R)-8ba 85 95 
11 -(CH2)4- 6c Ph 7a 4 (R)-8ca 92 93 
12 -(CH2)5- 6d Ph 7a 4 (R)-8da 90 93 
13 H Me 6e Ph 7a 1 (S,R)/(R,R)-8ea 99[d] 87/87 
14 H Bn 6f Ph 7a 1 (S,R)/(R,R)-8fa 99[e] 79/74 
[a] Isolated yield after flash chromatography. [b] Enantioselectivities determined by chiral HPLC. [c] Absolute configuration determined by the order of 
elution of the enantiomers in chiral HPLC (see Experimental Section and Supporting Information). [d] Mixture of diastereomers 1.2/1, determined by 1H 
NMR (300 MHz) in the reaction crude. [e] Mixture of diastereomers 1.9/1, determined by 1H NMR (300 MHz) in the reaction crude. 
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Non-N-arylated maleimides were also used for the conjugated 
addition with isobutyraldehyde. Thus, N-benzylmaleimide (7g) 
afforded quantitatively the corresponding succinimide (R)-8ag in 
87% ee, whereas N-methylmaleimide (7h) gave Michael adduct 
(R)-8ah also quantitatively in 89% ee (Table 2, entries 7 and 8). 
Furthermore, the simple maleimide (7i) yielded the succinimide 
(R)-8ai with an enantioselectivity of 84% and in quantitative yield 
(Table 2, entry 9). However, an oxygenated analogue such as 
maleic anhydride gave no reaction. 
Other α,α-disubstituted aldehydes were employed as pro-
nucleophiles for the organocatalyzed Michael addition reaction to 
N-phenylmaleimide. Thus, 2-ethylbutanal (6b) gave rise to 
succinimide (R)-8ba in 95% ee, whereas cyclopentane- (6c) and 
cyclohexanecarbaldehyde (6d) gave the corresponding 
succinimides (R)-8ca and (R)-8da both in 93% ee (Table 2, entries 
11 and 12). Moreover, the use of α-monosubstituted aldehydes 
such as propanal (6e) and 3-phenylpropanal (6f) afforded 
quantitatively the Michael adducts (S,R)/(R,R)-8ea and (S,R)/(R,R)-
8fa, respectively, as mixtures of diastereomers with 
enantioselections up to 87 and 79%, respectively, for the major 
isomer [Table 2, entries 13 and 14, see footnotes d) and e)]. 
The absolute configuration of the known succinimides was 
assigned according to the elution order of their enantiomers in 
chiral HPLC when compared to the literature (see Supporting 
Information), whereas the configuration of the new succinimides 
was assigned by analogy. In addition, aldehyde (R)-8ad resulted 
converted into the acid (R)-9ad upon standing in open air for 
several days. Crystallization of this compound in n-hexane/AcOEt 
afforded crystals which were used for X-ray analysis (Figure 1). 
The assigned (R)-stereochemistry was confirmed according to the 
Sheldrick least-squares refinement of the structure, which gave a 
Flack parameter of x = 0000(13). 
 
 
 
Figure 1. X-Ray structure of compound (R)-9ad. 
As an example of the synthetic usefulness of the obtained 
succinimides 8, their transformation to γ-lactams was carried out 
following a one-pot tandem reductive amination/lactamization 
sequence.[3] Thus, enantioenriched crude succinimide (R)-8aa 
(91% ee), obtained by evaporation of the solvent after the Michael 
addition reaction of isobutyraldehyde and N-phenylmaleimide 
(Table 2, entry 1), was dissolved in chloroform and treated with 
benzylamine and sodium triacetoxyborohydride. Subsequent 
spontaneous cyclization afforded lactam (R)-10aa in essentially the 
same enantioselectivity than the starting succinimide (90% ee) 
(Scheme 2).  
 
Scheme 2. Synthesis of γ-lactam (R)-10aa from enantioenriched 
succinimide (R)-8aa by a tandem reductive amination/lactamization 
sequence. 
 
 The sense of the enantioinduction achieved in this 
organocatalyzed reaction by using the primary amine-guanidines 5 
resulted rather unexpected. Thus, the observed (R)-stereochemistry 
in all the formed succinimides 8, which is achieved employing 
organocatalyst 5a derived from (1S,2S)-cyclohexane-1,2-diamine, 
is the same than the observed using as organocatalysts primary 
amine-thiourea 2, obtained from enantiomeric (1R,2R)-
cyclohexane-1,2-diamine.[8b] This would indicate that the reaction 
takes place through a different transition state, leading to an 
opposite stereoinduction. 
In order to get further insight into the origin of the observed 
enantioselectivity achieved by these primary amine-guanidines, 
and the intriguing enantioselectivity switch between thioureas and 
guanidines, we carried out theoretical calculations[13] to detail the 
H-bond activation patterns during the crucial C-C bond forming 
transition state. Structure optimizations were performed at 
B3LYP/6-311+G** level and single point energies were obtained 
at M06-2X/6-311+G** level, taking into account in both cases the 
solvent (water, IEFPCM) effects. We checked the reaction between 
substrates 6a and 7a in the presence of two catalysts, thiourea 2 
and guanidine 5a. We assumed that the reaction is initiated by the 
formation of a reactive enamine intermediate between the free NH2 
group of the catalyst and the aldehyde. The hydrogen-bonding 
interaction should then occur between maleimide and the NH 
functions (one or two NH) of thiourea and/or guanidine moieties. 
The first computational results showed that, as expected, the 
thiourea activates the maleimide substrate in a transition state 
leading preferentially to the R enantiomer [8.3 kcal/mol (R) vs 14.9 
kcal/mol (S), Figure 2]. The formation of two H-bonds in R and 
only one in S seems partially responsible for this preference. A 
closer analysis of the structures indicates that in TS1-S, the thiourea 
is also slightly distorted to accommodate the H-bond with the 
maleimide, which might induce the corresponding energy penalty. 
 
 
Figure 2. H-bond activation using thiourea 2 and guanidine 5a. Gibbs Free 
energy (G) values computed at M06-2X/6-311+G** (water) level. Values 
in parenthesis correspond to the B3LYP method. 
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 Meanwhile, we found that a similar disposition of the NH 
groups in the guanidine would lead to a similar enantiomeric 
preference (Figure 2), and the transition state TS2-S (10.7 kcal/mol) 
appeared highly favoured over TS2-R structure (16.3 kcal/mol). 
Attention must be drawn at this point to the fact that 2 and 5a 
belong to the opposite enantiomeric series (Figure 2), and thus the 
computational preference for R in thiourea 2 is equivalent to the 
preference for S in guanidine 5a. This is in obvious contradiction 
with the experimental results, which show a large enantiomeric 
excess in favour of the R form with both catalysts. We assumed 
that a different activation pattern was necessary to explain these 
experimental facts. In this regard, we found that the two main 
conformations of a model cyclohexyl-guanidine (structures G-1 
and G-2, Figure 3) do not actually present their NH groups in the 
parallel disposition necessary for the double H-bond activation 
(which is the case in TS2 transition states), but instead, the two NH 
groups are pointing toward opposite directions. In sharp contrast, 
the model cyclohexyl-thiourea presents two main conformations of 
similar energy (T-1 and T-2), and one of them displays the 
necessary NH disposition to reach TS1-type structures.[14] 
 
 
Figure 3.Most stable conformations of cyclohexyl-guanidines (G-1 and G-
2) and –thioureas (T-1 and T-2). 
 
 As a result, TS2 structures were not probably responsible for 
the activation exerted by guanidines. Indeed, after an important 
conformational search effort, a pair of structures (TS3-R and S, 
Figure 4) were located where the activation of the maleimide is 
achieved by a single NH bond pointing to the reaction centre, 
whereas the other NH points to the external face of the catalyst 
(like in G-1, Figure 3). One such transition state (TS3-R) shows the 
overall lowest activation energy found with 5a, and in agreement 
with the experimental results, it predicts the right R-enantiomer. 
Examination of the energies of the different transition states in 
Figures 2 and 4 leads to the conclusion that R enantiomer arises 
from TS3-R (8.9 kcal/mol), whereas S enantiomer arises from TS2-
S (10.7 kcal/mol). These data were obtained using the M06-2X 
method, which correctly predicts the experimental results. 
Although B3LYP shows a similar overall trend, it affords less 
conclusive data, as it shows closer energies for both enantiomers 
(14.1 kcal/mol in TS3-R, and 13.9 kcal/mol in TS2-S). 
 
 
Figure 4. H-bond activation using primary amine-guanidine 5a (G-1 type 
conformation). Gibbs Free Energy (G) values computed at M06-2X/6-
311+G** (water) level. Values in parenthesis correspond to the B3LYP 
method. 
Conclusions 
We conclude that primary amine-guanidines, prepared by a simple 
monoguanylation of enantiomerically pure trans-cyclohexane-1,2-
diamines behave as organocatalysts in the enantioselective 
conjugate addition of aldehydes, including α,α-disubstituted, to 
different maleimides leading to enantiomerically enriched 
succinimides. High yields and enantioselectivities can be achieved 
working in aqueous solvents and in the presence of imidazole as 
rate-accelerating additive. The obtained sense of enantioselectivity 
results opposite to that reported when primary amine-thioureas are 
employed as organocatalysts. Theoretical calculations suggest a 
different hydrogen bond-based coordination pattern between the 
organocatalyst and the maleimide in the case of these primary 
amine-guanidines and amine-thioureas. This produces a more 
favorable transition state when the maleimide is oriented opposite 
to when an amine-thiourea is involved, thus leading to an opposite 
enantioselection after internal attack of the formed enamine.  
Experimental Section 
General Methods: All the reagents and solvents employed were of the best 
grade available and were used without further purification. Melting points 
are uncorrected. Specific rotations were measured using a Perkin-Elmer 
341 polarimeter. IR data were collected on a Nicolet Impact 400D-FT 
spectrometer. The 1H and 13C NMR spectra were recorded at 25 ºC on a 
Bruker AC-300 at 300 MHz and 75 MHz, respectively, using TMS as 
internal standard. MS (EI, 70 eV) were performed on an Agilent MS 5973 
(DIP) and a HP MS-GC 5973A equipment. HRMS analyses were carried 
out on a Finnigan MAT 95S. Absolute configuration for adducts 8 was 
determined according to the described order of elution of their enantiomers 
in chiral HPLC. The absolute configuration of the new adducts 8af and 8ai 
was assigned by analogy. Reference racemic samples of adducts 8 were 
obtained by performing the reaction using 4-methylbenzylamine (20 mol-
%) as organocatalyst in toluene as solvent at 25 ºC. CCDC-930978 [for (R)-
9ad] contains the supplementary crystallographic data for this paper. These 
data can be obtained free of charge at 
www.ccdc.cam.ac.uk/conts/retrieving.html [or from the Cambridge 
Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; 
fax: (internat.) + 44-1223/336-033; Email: deposit@ccdc.cam.ac.uk]. 
 
Preparation of the Primary Amine-Guanidines: To a solution of (1S,2S)-
cyclohexane-1,2-diamine (for 5a,b) or (1R,2R)-cyclohexane-1,2-diamine 
(for ent-5a) (50 mmol, 5.71 g) in THF (10 mL) was added 
diisopropylcarbodiimide (for 5a and ent-5a) or dicyclohexylcarbodiimide 
(for 5b) (10 mmol) and the mixture was stirred at rt for 2 d. The solvent 
was evaporated (15 torr) and CH2Cl2 was added (20 mL). The solution was 
extracted with 2M HCl (3x10 mL) and the aqueous phase was basified with 
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2M NaOH until pH ≈ 9. Water was evaporated in vacuo (15 torr) and 
MeOH was added (50 mL). The solution was dried (MgSO4), filtered and 
evaporated in vacuo (15 torr) and the crude was purified by column 
chromatography (CH2Cl2/MeOH 8/2, v/v) affording 5a (1.20 g, 50%), 5b 
(1.60 g, 50%) or ent-5a (1.22 g, 51%). 
Physical and spectroscopic data for compounds 5a and 5b are given below:  
 
1-((1S,2S)-2-Aminocyclohexyl)-2,3-diisopropylguanidine (5a): Yellow 
solid; mp = 165 ºC (MeOH/Et2O); [α]20D = -46.7 (c 1, MeOH); IR (ATR): 
= 3252, 3193, 2973, 2934, 2865, 1607, 1389, 1370, 1167, 1132, 733 cm-1; 
1H NMR (300 MHz, CD3OD):δH = 3.99 (m, 4H), 1.94 (m, 1H), 1.76 (m, 
3H), 1.46 (m, 2H), 1.34 (m, 1H), 1.29 (d, J = 6.4 Hz, 6H), 1.28 (d, J = 6.4 
Hz, 6H); 13C NMR (75 MHz, CD3OD): δC = 154.2, 56.5, 45.8, 33.7, 25.4, 
22.8; MS (EI, 70 ev): m/z (%) = 240 (M+, 5), 144 (100); HRMS (EI): m/z 
calcd for C13H28N4: 240.2314; found: 240.2308. 
 
1-((1S,2S)-2-Aminocyclohexyl)-2,3-dicyclohexylguanidine (5b): White 
solid; mp = 184 ºC (MeOH/Et2O); [α]20D = -39.6 (c 1, MeOH); IR (ATR):  
= 3242, 3182, 2927, 2855, 1608, 1366, 1343, 1146, 1097, 727 cm-1; 1H 
NMR (300 MHz, CD3OD): δH = 7.33 (d, J = 9.0 Hz, 1H), 4.02 (m, 1H), 
3.63 (m, 2H), 3.45 (m, 1H), 1.87-1.08 (m, 28 H); 13C NMR (75 MHz, 
CD3OD): δC = 154.2, 56.6, 52.7, 34.6, 33.9, 33.8, 26.7, 26.2, 26.1, 26.0, 
25.4; MS (EI, 70 ev): m/z (%) = 320 (M+, 2), 224 (100); HRMS (EI): m/z 
calcd for C19H36N4: 320.2940; found: 320.2934. 
 
Typical Procedure for the Enantioselective Michael Addition Reaction: 
To a solution of 5 or ent-5a (0.04 mmol), the maleimide 7 (0.2 mmol) and 
imidazole (0.04 mmol) in DMF/H2O (2/1, v/v) (0.5 mL) was added the 
aldehyde 6 (0.4 mmol) and the mixture was stirred at 0 ºC until completion 
of the reaction (TLC). 2M HCl (10 mL) was added and the mixture was 
extracted with AcOEt (3x10 mL). The organic phase was washed with 
water (2x10 mL), dried (MgSO4), filtered and evaporated (15 torr). The 
resulting crude was purified by flash chromatography (n-hexane/AcOEt) 
affording adducts 8. 
Succinimides 8aa,[8b] 8ab,[8f] 8ac,[8b] 8ad,[8f] 8ae,[8f] 8ag,[8b] 8ah,[8b] 8ba,[8a] 
8ca,[8c] 8da,[8c] 8ea[8b] and 8fa[3a] have already been described and their 1H 
NMR and 13C NMR data and retention times in chiral HPLC for both 
enantiomers can be found in the Supporting Information. Full analytical, 
spectroscopical data and retention times observed in chiral HPLC for the 
new compounds 8af and 8ai, as well as for the oxidation product (R)-9ad, 
are given below: 
 
(R)-4-(3-(2-Methyl-1-oxopropan-2-yl)-2,5-dioxopyrrolidin-1-yl)phenyl 
acetate (8af): White solid; mp = 75 ºC (n-hexane/AcOEt); [α]20D = +1.1 (c 
1, CHCl3); IR (ATR):  = 3055, 2968, 2933, 1703, 1684, 1386, 1260, 1188, 
1170, 838, 742 cm-1; 1H NMR (300 MHz, CDCl3): δH = 9.49 (s, 1H), 8.05 
(d, J = 8.5 Hz, 2H), 7.44 (d, J = 8.5 Hz, 2H), 3.14 (dd, J = 9.6, 5.6 Hz, 1H), 
3.00 (dd, J = 18.3, 9.6 Hz, 1H), 2.63 (dd, J = 12.7, 5.6 Hz, 1H), 2.62 (s, 3H), 
1.38 (s, 3H), 1.30 (s, 3H); 13C NMR (75 MHz, CDCl3): δC = 202.8, 197.3, 
176.6, 174.5, 136.9, 136.0, 129.8, 129.3, 126.7, 48.9, 45.2, 32.2, 26.8, 20.7, 
20.1; MS (EI, 70 ev): m/z (%) =  303 (M+,0.02), 259 (100); HRMS (EI): 
m/z calcd for C16H17NO5: 303.1107; found: 303.1134; HPLC: Chiralpak 
AS-H, λ = 210 nm, n-hexane/2-propanol, 75:25, 1.0 mL/min, tr (minor) = 
50.2 min, tr (major) = 67.7 min. 
 
(R)-2-(2,5-Dioxopyrrolidin-3-yl)-2-methylpropanal (8ai): Colorless oil; 
IR (film):  = 3235, 3077, 2973, 2938, 1779, 1698, 1353, 1290, 1179, 804, 
659 cm-1; 1H NMR (300 MHz, CDCl3): δH = 9.49 (s, 1H), 8.73 (br s, 1H), 
3.10 (dd, J = 9.4, 5.8 Hz, 1H), 2.85 (dd, J = 18.4, 9.4 Hz, 1H), 2.51 (dd, J = 
18.4, 5.8 Hz, 1H), 1.25 (s, 3H), 1.23 (s, 3H); 13C NMR (75 MHz, CDCl3): 
δC = 202.9, 178.3, 176.2, 48.0, 46.3, 32.8, 20.1, 19.4; MS (EI, 70 ev): m/z 
(%) = 169 (M+, 0.66), 69 (100); HRMS (EI): m/z calcd for C8H11NO3: 
169.0739; found: 169.0738; HPLC: Chiralpak AD-H, λ = 210 nm, n-
hexane/2-propanol, 85:15, 1.0 mL/min, tr (major) = 22.5 min, tr (minor) = 
30.4 min. 
 
(R)-2-(1-(4-Bromophenyl)-2,5-dioxopyrrolidin-3-yl)-2-methylpropanoic 
acid (9ad): White solid; mp = 186 ºC (n-hexane/AcOEt). [α]20D = +1.6 (c 1, 
CHCl3); IR (ATR):  = 3000 (br), 2986, 1706, 1675, 1491, 1401, 1181, 781, 
723 cm-1; 1H NMR (300 MHz, CDCl3): δH = 7.58 (m, 2H), 7.15 (m, 2H), 
3.14 (dd, J = 9.5, 5.4 Hz, 1H), 3.05-2.96 (dd, J = 18.1, 5.4 Hz, 1H), 2.70 
(dd, J = 18.1, 5.4 Hz, 1H), 1.54 (s, 3H), 1.39 (s, 3H); 13C NMR (75 MHz, 
CDCl3): δC = 180.5, 176.5, 174.5, 132.4, 130.8, 128.1, 122.6, 47.0, 32.6, 
24.3, 23.6; MS (EI, 70 ev): m/z (%) = 338 (M+, 4.62), 57 (100); HRMS 
(EI): m/z calcd for C14H14BrNO4: 339.0106; found: 339.0128. 
 
One-pot Michael addition/Reductive amination/Lactamization: To a 
mixture of 1a (0.08 mmol, 19.2 mg), N-phenylmaleimide (0.4 mmol, 69.2 
mg) and imidazole (0.08 mmol, 4.8 mg) in DMF/H2O (2/1, v/v) (0.5 mL) 
was added isobutiraldehyde (0.8 mmol, 73 µL) at 0 ºC. The mixture was 
stirred at 0 ºC for 2 d and the solvent was evaporated till dryness (15 torr). 
The reaction crude was dissolved in CHCl3 (3.5 mL) and a 1M solution of 
benzylamine (0.8 mL, 0.8 mmol) in CHCl3 was added, and sodium 
triacetoxyborohydride (1 mmol, 211.9 mg). The mixture was stirred at rt for 
6 h and the solvent was evaporated in vacuo (15 torr). To the crude was 
added 2M HCl (5 mL) and the solution was extracted with CHCl3 (3x2 mL). 
The organics were dried (MgSO4), filtered and evaporated (15 torr). The 
resulting crude was purified by flash chromatography (n-hexane/AcOEt 
gradients) affording the γ-lactam (R)-10aa (60.6 mg, 45%). Physical and 
spectroscopic data for this compound are given below:  
 
(R)-2-(1-Benzyl-4,4-dimethyl-2-oxopyrrolidin-3-yl)-N-phenylacetamide 
(10aa): Yellow oil; [α]20D = +1.6 (c 1, CHCl3); IR (film):  = 3316, 3262, 
2986, 1675, 1491, 1401, 1181, 781, 723 cm-1; 1H NMR (300 MHz, CDCl3): 
δH = 7.62 (m, 2H), 7.41-7-18 (m, 7H), 7.12-7.01 (m, 1H), 4.60 (d, J = 14.6 
Hz, 1H), 4.38 (d, J = 14.6 Hz, 1H), 3.09 (d, J = 9.7 Hz, 1H), 2.86 (d, J = 9.7 
Hz, 1H), 2.81-2.63 (m, 2H), 2.30 (dd, J = 13.4, 0.8 Hz, 1H), 1.15 (s, 3H), 
0.88 (s, 3H); 13C NMR (75 MHz, CDCl3): δC = 176.4, 170.2, 138.8, 135.7, 
128.8, 128.2, 127.9, 123.6, 119.6, 58.9, 50.0, 46.9, 37.9, 34.6, 25.1, 21.8; 
MS (EI, 70 ev): m/z (%) = 336 (M+, 12.79), 244 (100); HRMS (EI): m/z 
calcd for C21H24N2O2: 336.1838; found: 336.1851; HPLC: Chiralpak AD, λ 
= 210 nm, n-hexane/2-propanol, 80:20, 1.0 mL/min, tr (major) = 8.6 min, tr 
(minor) = 9.9 min. 
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